ZGEN - BMO MSCI Genomic Innovation Index ETF (CAD) (CA05591N1033)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

Alle auswählen Alle zurücksetzen

Speichern Schließen

ETF & Funds ceased circulation

(%)

CA05591N1033

ZGEN ISIN

Exchange Traded Funds (ETF)

Fondstyp

BMO Global Asset Management

Anbieter

NAV pro Aktie

20/01/2021

Startdatum

1 Wiederholungen pro Jahr

Ausschüttung von Dividenden

CEOJLU

CFI

Ticker

Closed

Status

Equity

Investitionsobjekt

Biotech

Sektor

Global

Geographie

MSCI ACWI IMI Genomic Innovation Index

Benchmark

0.45 %

Gesamtkostenquote

2,93 Mio. CAD

Gesamtes Fondsvermögen | 05/12/2023

2,93 Mio. CAD

Aktien-Anlageklasse Volumen | 05/12/2023

Nein

UCITS

Letzte Daten zum

Letzte Daten zum 05/12/2023

Zum Vergleichen hinzufügen

Entdecken Sie die umfangreichste Datenbank

1 000 000

Anleihen weltweit

80 234

Aktien

167 970

ETF & Funds

80 000

Indizes

Verwalten Sie Ihr Portfolio auf effizienteste Weise

Bond-Screener
Watchlist
Excel-Add-In

Zugang erhalten

Kurs-Dynamik

Fund profile

The BMO MSCI Genomic Innovation Index ETF has been designed to replicate, to the extent possible, the performance of the MSCI ACWI IMI Genomic Innovation Index, net of expenses. The Fund captures this mega trend by investing in stocks that have high exposure to innovative genomic companies.

ZGEN profile

The BMO MSCI Genomic Innovation Index ETF (CAD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in Global. The BMO Global Asset Management fund’s base currency is CAD and the share class was registered 20.01.2021 with unique ISIN - CA05591N1033. The total expense ratio is 0.45%. The BMO MSCI Genomic Innovation Index ETF (CAD) pays dividends 1 time(s) per year.

ZGEN - BMO MSCI Genomic Innovation Index ETF (CAD) (CA05591N1033)

Kurs-Dynamik

Fund profile

ZGEN profile

Einkommens-Zahlung (CA05591N1033)

Andere ETFs und Fonds dieses Anbieters

Ähnliche Etf & Fonds